EQUITY (Tables)

12 Months Ended

Dec. 31, 2023

Equity [Abstract]

SCHEDULE OF ISSUANCE OF WARRANTS TO PURCHASE COMMON STOCK

	Number of underlying Common stock		Exercise price
Series E Warrants		198,159	$	27.0000
Series F Warrants		433,878	$	7.4250
Series G Warrants		1,092,344	$	10.2300
Series H Warrants		12,914,086	$	1.3827
Series I Warrants		12,914,078	$	1.3827
Series J Warrants		12,914,086	$	1.3827
Series K Warrants		12,914,078	$	1.3827
Underwriter Warrants		15,299	$	7.4250
Total Warrants		53,396,008	$

SCHEDULE OF STOCK OPTIONS GRANTED

	Year ended December 31
	2023					2022
	Number of options			Weighted average exercise price		Number of options			Weighted average exercise price
Outstanding - beginning of period		294,712			5.21		289,408		$	5.29
Granted		1,097,250			1.89		7,841			2.61
Forfeited		(12,266	)		4.00		(2,537	)		5.70
Outstanding- end of period		1,379,696			2.58		294,712		$	5.21
Exercisable at the end of the period		215,709			5.38		123,115			5.51

6) The following table summarizes information about stock options granted to non-employees:

	Year ended December 31
	2023				2022
	Number of options		Weighted average exercise price		Number of options		Weighted average exercise price
Outstanding - beginning of period		166,669		3.37		20,002		6.90
Granted		625,000		1.71		146,667		2.89
Outstanding - end of period		791,669		2.06		166,669		3.37
Exercisable at the end of the period		84,667		3.42		35,667		3.61

SCHEDULE OF RESTRICTED STOCK GRANTED TO EMPLOYEES

	Year ended December 31
	2023			2022
	Number of restricted stock
Outstanding - beginning of period		355,951			527,668
Granted		2,914,340			45,494
Forfeited		(29,695	)		(10,832	)
Vested		(186,510	)		(206,379	)
Outstanding - end of period		3,054,086			355,951

SCHEDULE OF RESTRICTED STOCK UNIT GRANTED TO EMPLOYEES

	Year ended December 31
	2023		2022
	Number of RSUs
Outstanding - beginning of period		237,078		237,078
Granted		1,045,150		-
Outstanding - end of period		1,282,228		237,078

SCHEDULE OF ADDITIONAL INFORMATION ABOUT ALL OPTIONS OUTSTANDING AND EXERCISABLE

	Outstanding as of December 31, 2023
Exercise price	Options outstanding		Weighted average remaining contractual life (years)		Options exercisable
$1.15-2.97		1,786,211		9.28		73,946
$3.30-4.12		227,932		8.53		95,075
$4.95-10.05		153,169		7.00		127,303
$16.50		4,053		6.01		4,053
		2,171,365		9.03		300,376

SCHEDULE OF FAIR VALUE OF OPTIONS GRANTED TO EMPLOYEES

	Year ended December 31
	2023	2022
Expected life	5.125-6.5 years	5.125-6.5 years
Risk-free interest rates	3.58%-4.73%	1.79%-2.88%
Volatility	109.62%-125.61%	127.43%-130.93%
Dividend yield	-	-

SCHEDULE OF ALLOCATION OF TOTAL SHARE-BASED COMPENSATION EXPENSE

	Year ended December 31
	2023		2022
	($ in thousands)
Cost of revenues	$	93	$	72
Research and development		649		582
Sales and marketing		416		318
General and administrative		3,332		1,380
	$	4,490	$	2,352